VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CRVL
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
CRVLCorVel Corporation
$64.33$3.3B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders

CRVL logoCorVel Corporation(CRVL)Earnings, Financials & Key Ratios

CRVL•NASDAQ•Insurance & Managed Care
$64.33
30.1× P/E·Price updated Jul 7, 2026
SectorFinancial ServicesIndustryInsurance BrokersSub-IndustryClaims and cost containment services
AboutCorVel Corporation provides workers' compensation, auto, liability, and health solutions for employers, third party administrators, insurance companies, and government agencies to assist them in managing the medical costs and monitoring the quality of care associated with healthcare claims. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement services, retrospective utilization review, facility claim review, professional review, pharmacy services, directed care services, Medicare solutions, clearinghouse services, independent medical examinations, and inpatient medical bill review. It also provides a range of patient management services, such as claims management, case management, 24/7 nurse triage, utilization management, vocational rehabilitation, and life care planning, as well as processing of claims for self-insured payors with respect to property and casualty insurance. The company was incorporated in 1987 and is headquartered in Fort Worth, Texas.Show more
  • Revenue$959M+7.0%
  • Combined Ratio85.07%-1.7%
  • Net Income$110M+16.0%
  • Return on Equity30.81%-7.8%
  • Medical Cost Ratio75.71%-1.1%
  • Operating Margin14.93%+10.7%
  • Net Margin11.51%+8.3%
  • ROA18.56%-2.4%
  • Equity / Assets61.31%+4.0%

CRVL Price & Volume

CorVel Corporation (CRVL) stock price & volume — 10-year historical chart

Loading chart...

Proprietary Technology Drives Sustained Margin Expansion

Investment Thesis • Updated 2026Q4

VerdictPositive
Growth:Stable
Profitability:Strong
Financial:Fortress
Cash Flow:Robust
Primary Risk:Medical labor cost inflation

Key Thesis Takeaways

  • CorVel demonstrates a compelling growth trajectory underpinned by its CareMC platform, which has successfully compressed the combined ratio from 89.1% in 2024Q4 to 84.0% in 2026Q4.
  • The company maintains a fortress balance sheet with near-zero debt, providing significant flexibility to fund ongoing share repurchases, which totaled $20.2M in 2026Q4.
  • However, investors should monitor potential margin compression risks as medical labor cost inflation may challenge the sustainability of current underwriting profitability.

Verdict Logic

the company's ability to scale operating income to $39.7M in 2026Q4 through proprietary technology integration suggests a durable competitive advantage despite potential medical labor cost headwinds.

CRVL Growth Metrics

CorVel Corporation (CRVL) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years6.65%
5 Years11.64%
3 Years10.08%
TTM7.03%

Profit CAGR

10 Years14.49%
5 Years18.94%
3 Years18.47%
TTM15.95%

EPS CAGR

10 Years4.11%
5 Years-3.06%
3 Years19.31%
TTM16.3%

Return on Capital

10 Years32.76%
5 Years37%
3 Years38.54%
Last Year37.82%

CRVL Recent Earnings

CorVel Corporation (CRVL) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
Q2 2026Latest
May 20, 2026
Metric
Actual
Est
EPS
$0.61
—
Rev
$249M
—
Q1 2026
Feb 3, 2026
Metric
Actual
Est
EPS
$0.47
—
Rev
$236M
—
Q4 2025
Nov 4, 2025
Metric
Actual
Est
EPS
$0.54
—
Rev
$240M
—
Q3 2025
Aug 5, 2025
Metric
Actual
Est
EPS
$0.52
—
Rev
$235M
—
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 20, 2026
$0.61
$249M
Q1 2026Feb 3, 2026
$0.47
$236M
Q4 2025Nov 4, 2025
$0.54
$240M
Q3 2025Aug 5, 2025
$0.52
$235M
Based on last 12 quarters of dataView full earnings history →

Latest CRVL News

Recent stock market news and headlines for CorVel Corporation (CRVL)

GlobeNewsWire·Jun 17, 2026
CorVel Launches Marketwise Repricing™ to Deliver Smarter, Market-Based Medical Cost Containment

FORT WORTH, Texas, June 17, 2026 (GLOBE NEWSWIRE) -- CorVel Corporation (Nasdaq: CRVL), a national provider of risk management solutions, today announced the launch of CorVel Marketwise Repricing™, a market-based medical bill repricing solution designed to enhance cost containment while fitting seamlessly into existing bill review programs. As medical billing continues to vary widely across states, providers, and care settings, traditional network and re-pricing approaches do not always reflect market pricing.

Peers Comparison

Key metrics vs top competitors for CorVel Corporation (CRVL)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
CRVL logoCRVLCorVel CorporationCurrent
$64.33$3.26B30.067.03%11.51%30.81%—
MGRC logoMGRCMcGrath RentCorp
$113.58$2.79B17.893.65%16.38%12.84%—
GBLI logoGBLIGlobal Indemnity Group, LLC
$25.05$359.5M14.312.02%7.45%0.02%—
MCRB logoMCRBSeres Therapeutics, Inc.
$8.14$78.41M12.72—-4088.84%-127.3%—
AMSF logoAMSFAMERISAFE, Inc.
$35.45$663.05M14.352.63%14.27%17.85%—
EHTH logoEHTHeHealth, Inc.
$1.62$50.34M-4.764.06%6.31%3.99%—

Compare CRVL vs Peers

CorVel Corporation (CRVL) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs MGRC

Most directly comparable listed peer for CRVL.

Scale Benchmark

vs UNH

Larger-name benchmark to compare CRVL against a more recognizable public peer.

Peer Set

Compare Top 5

vs MGRC, GBLI, MCRB, AMSF

CRVL SEC Filings & Documents

CorVel Corporation (CRVL) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 20, 2026·SEC

Material company update

Feb 3, 2026·SEC

Material company update

Nov 4, 2025·SEC

10-K Annual Reports

3
FY 2026

May 22, 2026·SEC

FY 2025

May 23, 2025·SEC

FY 2024

May 24, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

Feb 5, 2026·SEC

FY 2025

Nov 6, 2025·SEC

FY 2025

Aug 7, 2025·SEC

Get notified when CRVL posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

CRVL Frequently Asked Questions

CorVel Corporation (CRVL) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
How fast is CorVel Corporation growing?

CorVel Corporation (CRVL) grew revenue by 7.0% over the past year. This is steady growth.

Is CRVL profitable?

Yes, CorVel Corporation (CRVL) is profitable, generating $110.3M in net income for fiscal year 2026 (11.5% net margin).

Dividend & Returns
What is CRVL's return on equity?

CorVel Corporation (CRVL) has a return on equity (ROE) of 30.8%. This is excellent, indicating efficient use of shareholder capital.

Industry Metrics
What is CorVel Corporation's combined ratio?

CorVel Corporation (CRVL) has a combined ratio of 85.1%. A ratio below 100% indicates underwriting profitability.

What if you invested $1,000 in CRVL back in 1997?

Total return calculator · dividends reinvested · 29+ years of data

See returns →